These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 30803967)
21. Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals. Glupczynski Y; Bogaerts P; Deplano A; Berhin C; Huang TD; Van Eldere J; Rodriguez-Villalobos H J Antimicrob Chemother; 2010 May; 65(5):866-71. PubMed ID: 20200037 [TBL] [Abstract][Full Text] [Related]
22. Detection and characterisation of 16S rRNA methyltransferase-producing Pseudomonas aeruginosa from the UK and Republic of Ireland from 2003-2015. Taylor E; Jauneikaite E; Sriskandan S; Woodford N; Hopkins KL Int J Antimicrob Agents; 2022 Mar; 59(3):106550. PubMed ID: 35176475 [TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study. Slekovec C; Robert J; van der Mee-Marquet N; Berthelot P; Rogues AM; Derouin V; Cholley P; Thouverez M; Hocquet D; Bertrand X Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):921-926. PubMed ID: 30826996 [TBL] [Abstract][Full Text] [Related]
24. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea. Cho HH; Kwon GC; Kim S; Koo SH J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063 [TBL] [Abstract][Full Text] [Related]
25. Molecular epidemiological characteristics of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in southeast Shanxi, China. Bai Y; Gong YE; Shen F; Li H; Cheng Y; Guo J; Liu G; Ji AF J Glob Antimicrob Resist; 2024 Mar; 36():301-306. PubMed ID: 38272212 [TBL] [Abstract][Full Text] [Related]
26. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals. Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875 [TBL] [Abstract][Full Text] [Related]
27. A New Variant of 16S rRNA Methylase, RmtD3, in a Clinical Isolate of Pseudomonas aeruginosa in Myanmar. Tada T; Shimada K; Mya S; Zan KN; Kuwahara K; Kirikae T; Tin HH Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084752 [No Abstract] [Full Text] [Related]
28. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients. Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143 [TBL] [Abstract][Full Text] [Related]
32. First detection in Europe of the metallo-β-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa. Gilarranz R; Juan C; Castillo-Vera J; Chamizo FJ; Artiles F; Álamo I; Oliver A Clin Microbiol Infect; 2013 Sep; 19(9):E424-7. PubMed ID: 23656535 [TBL] [Abstract][Full Text] [Related]
33. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China. Li J; Zou M; Dou Q; Hu Y; Wang H; Yan Q; Liu WE Ann Clin Microbiol Antimicrob; 2016 May; 15(1):35. PubMed ID: 27215335 [TBL] [Abstract][Full Text] [Related]
34. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827 [TBL] [Abstract][Full Text] [Related]
35. Emergence of 16S rRNA methylase gene armA and cocarriage of bla(IMP-1) in Pseudomonas aeruginosa isolates from South Korea. Gurung M; Moon DC; Tamang MD; Kim J; Lee YC; Seol SY; Cho DT; Lee JC Diagn Microbiol Infect Dis; 2010 Dec; 68(4):468-70. PubMed ID: 20926221 [TBL] [Abstract][Full Text] [Related]
36. Occurrence of co-existing bla VIM-2 and bla NDM-1 in clinical isolates of Pseudomonas aeruginosa from India. Paul D; Dhar D; Maurya AP; Mishra S; Sharma GD; Chakravarty A; Bhattacharjee A Ann Clin Microbiol Antimicrob; 2016 May; 15():31. PubMed ID: 27154587 [TBL] [Abstract][Full Text] [Related]
37. High Rates of Aminoglycoside Methyltransferases Associated with Metallo-Beta-Lactamases in Multidrug-Resistant and Extensively Drug-Resistant El-Far A; Samir S; El-Gebaly E; Omar M; Dahroug H; El-Shenawy A; Soliman NS; Gamal D Infect Drug Resist; 2021; 14():4849-4858. PubMed ID: 34848977 [TBL] [Abstract][Full Text] [Related]
38. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom. Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973 [TBL] [Abstract][Full Text] [Related]
39. Clonal Transmission of Gram-Negative Bacteria with Carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian Hospital. Pfeifer Y; Trifonova A; Pietsch M; Brunner M; Todorova I; Gergova I; Wilharm G; Werner G; Savov E Microb Drug Resist; 2017 Apr; 23(3):301-307. PubMed ID: 27459019 [TBL] [Abstract][Full Text] [Related]
40. Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers. Giani T; Arena F; Pollini S; Di Pilato V; D'Andrea MM; Henrici De Angelis L; Bassetti M; Rossolini GM; J Antimicrob Chemother; 2018 Mar; 73(3):664-671. PubMed ID: 29216350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]